OM Pharma

OM Pharma is a company focused on transforming immune health through its expertise in bacterial lysates. Since its establishment in 1937, the company has been addressing global health challenges, particularly in infectious disease outbreaks and antimicrobial resistance. Currently, OM Pharma is actively involved in the prevention of respiratory and urinary tract infections. Their continuous research and development efforts have led to a deeper understanding of how bacterial lysates interact with the immune system, driving investments in new indications and formulations for their products. With its headquarters in Geneva and affiliates in Peru and Switzerland, OM Pharma has established a global presence, making its products available in more than 100 countries through a network of trusted partners. Although the details of their last investment and investors are not available, OM Pharma's commitment to developing innovative solutions for global health challenges positions it as an intriguing prospect for potential venture capital involvement.